Subtype
Male Reproductive System Neoplasm
CI-CAN-00001107Explore in graph →
Non-malignant1,533 active trials27 approved drugs58 evidence items
- NCIt
- C3054
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001107Explore in graph →
Clinical trials
6,899 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00196781 | Treatment Decision Making in Early-Stage Prostate Cancer | completed | Phase 3 | 168 | Georgetown UniversityOTHER | 1 | Jan 13, 2010 | clinicaltrials |
| NCT00136487 | Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer | completed | Phase 2 / Phase 3 | 85 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 9, 2009 | clinicaltrials |
| NCT00391950 |
| Maintaining Bone Strength in Men With Prostate Cancer |
| terminated |
| Phase 3 |
| 300 |
| NovartisINDUSTRY |
| 1 |
| Nov 23, 2009 |
| clinicaltrials |
| NCT00043576 | ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere | unknown | Phase 2 / Phase 3 | 250 | NovaceaINDUSTRY | 2 | Mar 12, 2009 | clinicaltrials |
| NCT00841113 | Abarelix Versus Goserelin Plus Bicalutamide in Patients With Advanced or Metastatic Prostate Cancer | completed | Phase 3 | 177 | Speciality European Pharma LimitedINDUSTRY | 0 | Feb 11, 2009 | clinicaltrials |
| NCT00089856 | GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer | terminated | Phase 3 | 626 | Cell GenesysINDUSTRY | 8 | Nov 5, 2008 | clinicaltrials |
| NCT00764166 | A Prospective Randomized Phase III Study Comparing Hormonal Therapy +/-Docetaxel(RisingPSA) | unknown | Phase 3 | 254 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Oct 1, 2008 | clinicaltrials |
| NCT00133224 | Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients | terminated | Phase 3 | 408 | Cell GenesysINDUSTRY | 10 | Sep 23, 2008 | clinicaltrials |
| NCT00489060 | A Randomized Trial of External Beam Radiotherapy Versus Cryoablation in Patients With Localized Prostate Cancer | completed | Phase 3 | 244 | University of CalgaryOTHER | 1 | Jul 17, 2008 | clinicaltrials |
| NCT00692107 | Radiotherapy for Prostate Cancer: Conventional Dose Versus High Dose | completed | Phase 3 | 669 | The Netherlands Cancer InstituteOTHER | 1 | Jun 6, 2008 | clinicaltrials |
| NCT00076531 | Clinical Trial for Prostate Cancer | completed | Phase 3 | — | Oakwood Laboratories, LLCINDUSTRY | 0 | Jan 28, 2008 | clinicaltrials |
| NCT00127478 | A Long Term Safety Study With Atrasentan | completed | Phase 2 / Phase 3 | 166 | AbbottINDUSTRY | 5 | Nov 29, 2007 | clinicaltrials |
| NCT00128531 | Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer | completed | Phase 3 | 120 | GP-PharmINDUSTRY | 9 | Nov 14, 2007 | clinicaltrials |
| NCT00273338 | DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2]) | terminated | Phase 3 | 1,200 | NovaceaINDUSTRY | 9 | Nov 6, 2007 | clinicaltrials |
| NCT00548600 | Radical Radiotherapy by External Beam Radiation Versus Radical Radiotherapy With Temporary Iridium Implant Plus External Beam Radiation in Carcinoma of the Prostate | completed | Phase 3 | 112 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Oct 24, 2007 | clinicaltrials |
| NCT00421694 | Positive Surgical Margins Rate and EGFR Family Members Expression in Prostate Cancer Treated With Bicalutamide | completed | Phase 2 / Phase 3 | 119 | University of L'AquilaOTHER | 1 | Oct 8, 2007 | clinicaltrials |
| NCT00036556 | Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer | completed | Phase 3 | 941 | AbbottINDUSTRY | 17 | Aug 15, 2007 | clinicaltrials |
| NCT00294151 | Potential Vertebroplasty Use in the Treatment of Vertebral Metastasis From Breast and Prostate Cancer | unknown | Phase 3 | 30 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Jul 13, 2007 | clinicaltrials |
| NCT00494039 | I-125 Versus Pd-103 for Low Risk Prostate Cancer | unknown | Phase 3 | 602 | VA Puget Sound Health Care SystemFED | 1 | Jun 29, 2007 | clinicaltrials |
| NCT00494546 | High Versus Low Dose Supplemental External Radiation With Pd-103 for Prostate Cancer | completed | Phase 3 | 568 | VA Puget Sound Health Care SystemFED | 1 | Jun 29, 2007 | clinicaltrials |
| NCT00486499 | I-125 Versus Pd-103 for Medium Risk Prostate Cancer | unknown | Phase 3 | 660 | VA Puget Sound Health Care SystemFED | 1 | Jun 14, 2007 | clinicaltrials |
| NCT00036543 | A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer | completed | Phase 3 | 1,000 | AbbottINDUSTRY | 18 | Aug 15, 2006 | clinicaltrials |
| NCT00201630 | Prophylactic Vs. Therapeutic Use of Uroxatrol in Men Undergoing Brachytherapy | unknown | Phase 3 | 150 | New York Prostate InstituteOTHER | 1 | Sep 20, 2005 | clinicaltrials |
| NCT00164437 | CD-ROM Intervention for Prostate Cancer Screening | completed | Phase 2 / Phase 3 | 554 | Centers for Disease Control and PreventionFED | 1 | Sep 14, 2005 | clinicaltrials |
| NCT00122499 | A Study to Assess the Efficacy of Tadalafil to Treat Erectile Dysfunction After Radiotherapy of Prostate Cancer | completed | Phase 3 | — | Erasmus Medical CenterOTHER | 1 | Jul 27, 2005 | clinicaltrials |
Data updated 23 days agoSource updated Jan 13, 2010source: clinicaltrials